Limbic
PrivateLast Round
Series A
Mar 5, 2024
Total Funding Raised
$16.75M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Limbic is a clinical artificial intelligence company that develops AI-powered tools for mental healthcare, including patient intake, triage, and therapy support platforms.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical AI, Patient Engagement, NLP & Conversational AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Limbic Comparables
Compare Limbic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wysa | 76% | |
| Woebot Health | 74% | |
| Upheal | 72% | |
Limbic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 5, 2024 | ||||
| Seed | Nov 24, 2021 | ||||
| Grant | May 1, 2020 | ||||
| Grant | May 1, 2020 | ||||
| Grant | Jan 1, 2020 |
Key People
Founding team and executive leadership
Limbic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Khosla Ventures | Series A |
| European Commission | Seed |
| Gaingels | Series A |
| 7 Percent Ventures | Seed |
| Innovate UK | Seed |
| Joyance Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Launching new 'AI therapist' product for end-to-end care in the US.
- Apr 1, 2026
NHS is a customer, using technology in over 50% of services.
Limbic Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Limbic's valuation, stock price, and market status.